BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24369144)

  • 1. Radioiodine therapy for castration-resistant prostate cancer following prostate-specific membrane antigen promoter-mediated transfer of the human sodium iodide symporter.
    Gao XF; Zhou T; Chen GH; Xu CL; Ding YL; Sun YH
    Asian J Androl; 2014; 16(1):120-3. PubMed ID: 24369144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer.
    Kakinuma H; Bergert ER; Spitzweg C; Cheville JC; Lieber MM; Morris JC
    Cancer Res; 2003 Nov; 63(22):7840-4. PubMed ID: 14633711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells.
    Li W; Tan J; Wang P; Wu P
    Cancer Biother Radiopharm; 2011 Aug; 26(4):443-51. PubMed ID: 21797672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase reverse transcriptase promoter-driven expression of iodine pump genes for targeted radioiodine therapy of malignant glioma cells.
    Tan J; Li W; Wang P
    Chin J Cancer; 2011 Aug; 30(8):574-80. PubMed ID: 21801606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the optimal time for radioiodine therapy in anaplastic thyroid carcinoma using the adenovirus-mediated transfer of sodium iodide symporter gene.
    So Y; Lee YJ; Lee WW; Chung JK
    Oncol Rep; 2013 Apr; 29(4):1666-70. PubMed ID: 23404348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial fibrillary acidic protein promoters direct adenovirus early 1A gene and human telomerase reverse transcriptase promoters direct sodium iodide symporter expression for malignant glioma radioiodine therapy.
    Li W; Tan J; Wang P; Li N; Li C
    Mol Cell Biochem; 2015 Jan; 399(1-2):279-89. PubMed ID: 25410753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radioiodide treatment mediated by adenovirus transfer of human sodium iodide symporter gene into androgen-independent prostate cancer].
    Huang R; Ma X; Li S; Mu D; Gong R; Kuang A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Oct; 27(5):1080-4. PubMed ID: 21089675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
    Spitzweg C; Zhang S; Bergert ER; Castro MR; McIver B; Heufelder AE; Tindall DJ; Young CY; Morris JC
    Cancer Res; 1999 May; 59(9):2136-41. PubMed ID: 10232600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced anti-tumor effects of combined MDR1 RNA interference and human sodium/iodide symporter (NIS) radioiodine gene therapy using an adenoviral system in a colon cancer model.
    Ahn SJ; Jeon YH; Lee YJ; Lee YL; Lee SW; Ahn BC; Ha JH; Lee J
    Cancer Gene Ther; 2010 Jul; 17(7):492-500. PubMed ID: 20186172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancer.
    Trujillo MA; Oneal MJ; McDonough S; Qin R; Morris JC
    Gene Ther; 2010 Nov; 17(11):1325-32. PubMed ID: 20428214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant adenovirus mediated prostate-specific enzyme pro-drug gene therapy regulated by prostate-specific membrane antigen (PSMA) enhancer/promoter.
    Zeng H; Wei Q; Huang R; Chen N; Dong Q; Yang Y; Zhou Q
    J Androl; 2007; 28(6):827-35. PubMed ID: 17522418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The glial fibrillary acidic protein promoter directs sodium/iodide symporter gene expression for radioiodine therapy of malignant glioma.
    Li W; Tan J; Wang P; Li N; Zhang F
    Oncol Lett; 2013 Feb; 5(2):669-674. PubMed ID: 23420532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
    Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression.
    Spitzweg C; Baker CH; Bergert ER; O'Connor MK; Morris JC
    Hum Gene Ther; 2007 Oct; 18(10):916-24. PubMed ID: 17931047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo sodium iodide symporter gene therapy of prostate cancer.
    Spitzweg C; Dietz AB; O'Connor MK; Bergert ER; Tindall DJ; Young CY; Morris JC
    Gene Ther; 2001 Oct; 8(20):1524-31. PubMed ID: 11704812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific activation of sodium iodide symporter gene in hepatoma using alpha-fetoprotein promoter combined with hepatitis B virus enhancer (EIIAPA).
    Liu RS; Hsieh YJ; Ke CC; Chen FD; Hwu L; Wang FH; Hwang JJ; Chi CW; Lee CH; Yeh SH
    Anticancer Res; 2009 Jan; 29(1):211-21. PubMed ID: 19331152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the human sodium/iodide symporter (hNIS) in xenotransplanted human thyroid carcinoma.
    Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Romijn JA; van der Heide D
    Exp Clin Endocrinol Diabetes; 2001; 109(1):52-5. PubMed ID: 11573141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transfer of sodium iodide symporter gene into glioma cells by recombinant adenovirus and radioiodine therapy for the glioma cells in vitro and in nude mice].
    Li W; Tan J; Zheng W; Li N
    Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):101-4. PubMed ID: 21575476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium/iodide symporter gene transfection increases radionuclide uptake in human cisplatin-resistant lung cancer cells.
    Chai W; Yin X; Ren L; Cai M; Long T; Zhou M; Tang Y; Yang N; Hu S
    Clin Transl Oncol; 2015 Oct; 17(10):795-802. PubMed ID: 26115738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium-iodine symporter gene expression controlled by the EGR-1 promoter: biodistribution, imaging and in vitro radionuclide therapy with Na(131)I.
    Tang J; Wang X; Xu Y; Shi Y; Liu Z; Yang Y
    Technol Cancer Res Treat; 2015 Feb; 14(1):61-9. PubMed ID: 24354753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.